DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
QUEST DIAGNOSTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026
$234.91−0.09 (-0.04%)
Close on Oct 19, 2026
- Market cap
- $26.31B
- P/E (TTM)
- 25.0
- Dividend yield
- –
Share price
+$45.40 (+23.96%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
QUEST DIAGNOSTICS INC grew revenue 9.9% to $11.56B over the twelve months to Jun 30, 2026. Operating income rose 10.5% to $1.63B, moving the operating margin from 14.0% to 14.1%. Free cash flow was $1.35B, up 10.2% from a year earlier.
Revenue
$11.56B
+9.9% vs. a year earlier
Operating income
$1.63B
+10.5% vs. a year earlier
Free cash flow
$1.35B
+10.2% vs. a year earlier
EPS, diluted
$9.41
+13.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $26.31B
- P/E ratio
- 25.0
- Price to sales
- 2.28
- Price to book
- 3.50
- Dividend yield
- –
- Free cash flow yield
- 5.13%
Fundamentals
- Revenue
- $11.56B
- Net income
- $1.06B
- EPS, diluted
- $9.41
- Free cash flow
- $1.35B
- Book value per share
- $67.11
- Diluted shares
- 112M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$11.56B+9.9% YoY
Gross profit
$3.83B+10.2% YoY
Operating income
$1.63B+10.5% YoY
Net income
$1.06B+11.8% YoY
EPS, diluted
$9.41+13.2% YoY
Free cash flow
$1.35B+10.2% YoY
Reported periodTrailing twelve months